City

New York (2)

Condition

Neurofibromatosis Type 2 (2)

Vestibular Schwannomas (2)

Meningiomas (1)

Overall Status

Completed (2)

Sign in for free

Phase

early phase 1 (1)

phase 2 (1)

Sponsor

NYU Langone Health (2)

Collaborator

Intervention

axitinib (1)

rad001 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

vestibular schwannomas

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neurofibromatosis Type 2, Vestibular Schwannomas Trial in New York (Axitinib)

Completed

Neurofibromatosis Type 2
Vestibular Schwannomas

Axitinib

New York, New York

NYU Langone Medical Center

Nov 24, 2021

Neurofibromatosis Type 2, Vestibular Schwannomas, Meningiomas Trial in New York (RAD001)

Completed

Neurofibromatosis Type 2
+2 more

RAD001

New York, New York

New York University School of Medicine

May 12, 2020